Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics. (2020)

First Author: Bovijn J


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aay6570

PubMed Identifier: 32581134

Publication URI: http://europepmc.org/abstract/MED/32581134

Type: Journal Article/Review

Volume: 12

Parent Publication: Science translational medicine

Issue: 549

ISSN: 1946-6234